In an ever-busy clinical landscape and the rise of ADC patient resistance, the role of combinations has become more important than ever to bring better ADC treatments to oncology patients faster. Join this long-standing seminar day to overview ADC clinical combination leaders, assess applications of dual payload ADCs to tackle patient payload resistance, and delve into rationale-driven practices to smartly select and investigate the right ADC combination partners.